H2020Staff exchange2021–2025

MYCOBIOMICS · Joining forces to exploit the mycobiota of Asia, Africa and Europe for beneficial metabolites and potential biocontrol agents, using -OMICS techniques

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2021-04-01 → 2025-09-30
EU contribution
€1,375,400
Participants
8
Scheme
MSCA-RISE

Lines connect the coordinator with its partners.

Results in brief

Joining forces to exploit the mycobiota of Asia, Africa and Europe for beneficial metabolites and potential biocontrol agents, using -OMICS techniques

The issue being addressed in this project is to exploit the hitherto untapped fungal organisms from different continents, study their biodiversity using state of the art technologies such as genomic, bioinformatics and analytical chemistry for beneficial and detrimental properties. Our consortium forms an international, interdisciplinary network composed of globally leading scientists in the above fields, which appears ideal to train the young generation of scientists, in order to tackle important challenges that are related to the aforementioned topics. Due to big threat that is being posed by the worldwide increasing antimicrobial resistance, there is a great need for novel anti-infectives. Exemplified by penicillin, fungal metabolites have often been used as starting points for the development of new drugs. Certain fungi can be developed into biological control agents that may replace hazardous agrochemicals and thereby contribute to a more sustainable agriculture. On the other hand, fungi also produce detrimental compounds like mycotoxins that are highly problematic because they accumulate in food and feeds. Our project is aimed at training of early stage researchers so they can characterize the respective organisms and monitor production of their metabolites. Our work program also includes various interactions with local mycological associations in which we are conduction joint fieldwork and various dissemination activities that are also targeting the citizen scientists and the public. The main objectives of this project can be summarized as follows 1. Establish a polythetic taxonomy of selected groups of Ascomycota (Hypocreales, Xylariales, Agaricomycetes) 2. Discovery of novel anti-infective secondary metabolites from fungi; in-depth biological characterization and development of sustainable processes for production of selected compounds 3. Studies on the production of mycotoxins and other secondary metabolites in the important ascomycete genera Fusarium (important pathogens!) and Trichoderma (important biocontrol agents and industrial enzyme producers) 4. Identification of biosynthesis gene clusters (BGC) encoding for secondary metabolites in all the above fungal groups 5. Functional analysis of the BGC and studies of their role in chemical ecology with respect to the potential of the producer organisms as biocontrol agents. 6. Demonstration of the respective techniques through secondments and training of young mycologists 7. Make the results of the work program available to a broad international audience, including various groups of stakeholders as well as the general public The ER and ESR from EU countries are receiving training in methods and techniques that are not available in their home institutes. The consortium has access to genetic resources including endemic African and Asian fungi that are not available in the EU territory, and any result that leads to the development of a product will become the subject of joint exploitation by the project partners.

Data: CORDIS, © European Union

Project objective

The proposed project embarks on a previous collaboration in the framework of H2020-MSCA-RISE “GoMyTRi” that has successfully laid the groundwork for an international collaboration involving three worldwide leading research infrastructures from Germany, the Netherlands, and Thailand. The common research interest of the partners is basic and applied mycology, and they joined forces to explore the beneficial secondary metabolites for development of antibiotics, and to find potential candidates for development of environmentally friendly fungal biocontrol agents. The interdisciplinary training conducted in the course of “GoMyTri” has already resulted in several joint scientific publications, and some of the PhD candidates involved have graduated with excellent grades, while some of the postdoctoral researchers involved have gained valuable experience in project management. During the past years, the collaboration has been consolidated and the partners have also been changing the scope of their respective research agendas. The new proposal aims to expand the collaboration by adding further, carefully selected partners from Austria, the Czech Republic, Kenya and South Africa, which have an excellent scientific track record and bring in additional know-how and expertise. The new objectives have been expanded to the implementation of –OMICS technologies and studies on the interaction of fungal organisms in order to discover newbioactive molecules. Furthermore, the project aims at characterization of the mycobiota of important agricultural plants. The scientists involved in the training program will thus be working in an interdisciplinary scenario that is intended to tackle several important global challenges at once and be given the opportunity to learn many important methods and techniques that are essential for studies of beneficial as well as detrimental fungal organisms. In addition, several dissemination events are planned.

Original text from CORDIS.

Participants

  • HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH · BraunschweigCoordinatorGermany
  • AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH · WienAustria
  • EGERTON UNIVERSITY · Njoro NakuruKenya
  • KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW · AMSTERDAMNetherlands
  • MIKROBIOLOGICKY USTAV AV CR V.V.I · PRAHA 4Czechia
  • NATIONAL SCIENCE & TECHNOLOGY DEVELOPMENT AGENCY · Klong 1 KlongluangThailand
  • UNIVERSITAET FUER BODENKULTUR WIEN · WienAustria
  • UNIVERSITY OF PRETORIA · PretoriaSouth Africa

Links

Data: CORDIS, © European Union